article thumbnail

Medical Devices Are Evolving Toward Specialized Solutions

MedCity News

As medical devices evolve and become more sophisticated, we are seeing a trend toward specialization. Building customized solutions for specialized disease states creates a nimbleness to respond to new conditions and develop a platform uniquely suited for that condition. It will become commonplace to see devices that break new ground.

article thumbnail

Weekly Roundup – Jan 4, 2019

CloserIQ

How to Give Your Resume a Makeover for 2019 (Eileen Hoenigman Meyer of Glassdoor). 5 Results-oriented Sales Tips to Give you a Head Start in 2019 (Neha Tandon of TechnologyAdvice). 7 ways to streamline your hiring process in 2019 (Lindsay Tigar of FastCompany). What’s Coming: Tech Hiring Predictions For 2019 (Forbes).

Sales 45
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

Our Best of 2018- to Fuel Your Best 2019

Integrity Solutions

Here is some of our ‘Best of 2018’ content that can help fuel thoughts, discussions and strategies to make 2019 your best year yet. Thank you to all our clients, partners and of course our employees for making 2018 a special year for Integrity Solutions. We look forward to serving the world with integrity even more in 2019.

article thumbnail

You get what you agree to, at least when it comes to the money under VPAS

pharmaphorum

The 2019 VPAS , just like its predecessor that was in place from 2014, has at its heart a payback mechanism. That is why companies who are members of the 2019 VPAS have collectively paid back almost £3 billion to the Department of Health and Social Care (DHSC) up to Quarter 2 of 2022. Predictable for government. Variable for companies.

article thumbnail

Medicinal cannabis: the route to good manufacturing practice registration

European Pharmaceutical Review

Celadon was the first company to work through the ‘chicken and egg’ situation with the Home Office and MHRA in 2019-20, as we weren’t prepared to break the law to grow medicinal cannabis in order to gain GMP! How do you see the evolution of cannabis-based medicines, particularly when it comes to the ‘specials’ or fully licensed drug routes?

Medicine 132
article thumbnail

Trying to get clarity on CDF and VPAS and implications for the IMF

pharmaphorum

2019 VPAS shapes commercial realities for companies. The 2019 VPAS is the latest in a long line of negotiated agreements that cover NHS spending on branded medicines, running from 1 January 2019 and due to end on 31 December 2023. The CDF predates the 2019 VPAS by nine years. No mention of the CDF is in the annexes.

article thumbnail

The Caregiver Vertical: How Pharma Engages

Pharma Marketing Network

2 In 2019, there were 7 potential family caregivers per older adult. Sunny’s healthcare marketing agency, Xavier Creative House, specializes in pharmaceutical, biotech, and medical device. February 2019. Reach out at swhite@xaviercreative.com. Connect at linkedin.com/in/sunnywhite/ . REFERENCES: Gilda’s Club. Public Health.

Pharma 98